1- Vieira VM, Hart JE, Webster TF,Weinberg J, Puett R,Laden F, et al. Association between residences in U.S. northern latitudes and rheumatoid arthritis: a spatial analysis of the Nurses’ Health Study. Environmental Health Perspectives. 2010;118(7):957-61.
2- Holick MF . Vitamin D: a millennium perspective. Journal of Cellular Biochemistry. 2003;88:296-307.
3- Pelajo CF , Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmunity Reviews. 2010;9(7):507-10.
4- Shoenfeld N , Amital H,S hoenfeld Y. The effect of melanism and vitaminD synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol. 2009;5:99-105.
5- Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cellular Immunology. 2005;233:115-24.
6- Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, et al Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitaminD, and TPA levels in autoimmune diseases. Ann NY Acad Sci. 2007;1109:385-400.
7- Veldman CM , Cantorna MT, DeLuca HF. Expression of 1,25- Dihydroxy vitamin D(3) receptor in the immune system. Arch Biochem Biophys. 2000;374(2):334-8.
8- Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, Ohmori H, Kamimura T. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1 alpha, 25-Dihydroxy vitamin D3. Immunopharmacol Immunotoxicol. 2002;24(3):335-47.
9- Gauzzi MC , Purificato C, Donato K, Jin Y, Wang L, et al. Suppressive effect of 1 alpha, 25-dihydroxy vitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. The Journal of Immunology. 2005;174:270-6.
10- Helming L, Bose J, Ehrchen J, Schiebe S, Frahm T, Geffers R, et al. 1 alpha, 25-Dihydroxy vitamin D3 is a potent suppressor of interferon gamma- mediated macrophage activation. Blood. 2005;106(13):4351-8.
11- Linker-Israeli M, Elstner E, Klinenberg JR, Wallace DJ, Koeffler HP. Vitamin D(3) and its synthetic analogs inhibits the spontaneous in vitro immunoglobulin production by SLE-derived PBMC. Clin Immunol. 2001;99(1):82-93.
12- Mahon B.D,Wittke A,Weaver.V, et al. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. Cell Biochem. 2003;89:922-32.
13- Steinman L. A brief history of T(H)17,the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med. 2007;13(2):139-45.
14- Dardalhon V, Korn T, Kuchroo VK , Anderson AC. Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008;31:252-6.
15- Yang J, Chu Y, Yang X,Gao D,et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis and Rheumatism. 2009;60(5):1472-83.
16- Kleczynska W, Jakiela B, Plutecka H,Milewski M,Sanak M,Musial J. Imbalance between Th17 and regulatory T-cells in systemic lupus erythematosus. Folia Histochemica Et Cytobiologica. 2011;49(4):646-53.
17- Stockinger B. Th17 cells: an orphan with influence. Immunol Cell Biol. 2007;85(2):83.
18- Arnson Y, Shoenfeld Y. Vitamin D and autoimmunity : new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66:1137-42.
19- Penna G, Adorini L. 1 Alpha, 25-dihydroxy vitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive Tcell activation. J Immunol. 2000;164(5):2405-11.
20- Kwan BCH, Tam LS, Lai KB,Lai FMM,et al. The gene expression of type 17 T-helper cell-related cytokines in the urinary sediment of patients with systemic lupus erythematosus. 2009;48:1491-7.
21- Palmer MT, Lee YK,Maynard CL,Oliver JR,Bikle DD,Jetten AM,Weaver CT. Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells. The Journal Of Biological Chemistry. 2011;286(2):997-1004.
22- Xing Q, Wang B, Su H, Cui J, Li J. Elevated Th17 cells are accompanied by FoxP3+ Treg cells decrease in patients with lupus nephritis.Rheumatol Int. 2011;1771:296-310|
23- Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, Kang I. Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(2):R53.
24- Hedrich CM , Rauen T, Kis-Toth K, Kyttaris VC, Tsokos GC. cAMP response element modulator (CREM)α suppresses IL-17F expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). J Biol Chem. 2011;287:4715-25
25- Joshi S , Pantalena LC, Liu XK, Gaffen SL, Liu H, Rohowsky-Kochan C, Ichiyama K, Yoshimura A, Steinman L, Christakos S, Youssef S. 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol. 2011;31(17):3653-69.